Navigation Links
Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
Date:5/18/2009

HOUSTON, May 18 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Bryan D. Olin, Ph.D., joined Cyberonics as Vice President, Quality, effective on May 18, 2009. Dr. Olin will lead all of the company's quality programs.

Dr. Olin joins Cyberonics from Zeltiq Aesthetics, an aesthetics device firm in California, where he served as Senior Director, Quality Assurance, since October 2007. Prior to Zeltiq, Dr. Olin was employed as Executive Director, Failure Analysis, Product Quality Services and Product Safety with Cordis Corporation, a Johnson & Johnson company. Dr. Olin spent five years with another Johnson & Johnson company, LifeScan, as the Manager, Statistical Engineering; Senior Program Manager, QA; Director, Complaint Handling and QA Laboratories; and Director, Clinical Biometrics and Complaint Management. Dr. Olin began his business career as a Statistician for Procter & Gamble, providing statistical support to a diverse set of internal clients in R&D and manufacturing.

"Bryan brings substantial expertise in quality management that will be helpful in all aspects of our regulated business, including manufacturing and product development," said Dan Moore, Cyberonics' President and Chief Executive Officer. "He has extensive experience with regulatory inspections and submissions, complaint handling, CAPAs and clinical study design. We are pleased to have Bryan joining our team to lead the global quality system and programs."

Dr. Olin received a B.S. in Mathematics from the University of Kansas. He was awarded a Masters of Science and his Ph.D. in Statistics from Iowa State University. Dr. Olin served as an Adjunct Assistant Professor of Industrial Pharmacy at the University of Cincinnati for three years.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (NASDAQ: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at www.cyberonics.com and www.vnstherapy.com.

Contact information

    Greg Browne, CFO
    Cyberonics, Inc.
    100 Cyberonics Blvd.
    Houston, TX 77058
    Main:  (281) 228-7262
    Fax:  (281) 218-9332
    ir@cyberonics.com


'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Financial Results
2. Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter
3. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Third Quarter Financial Results
4. Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development
5. Cyberonics to Present at Piper Jaffray 20th Annual Health Care Conference
6. Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter
7. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results
8. Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
9. Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike
10. Cyberonics to Present at UBS Global Life Sciences Conference
11. Cyberonics to Present at Canaccord Adams 28th Annual Global Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
Breaking Medicine Technology: